Home > Articles > Published articles > Ways forward for tolerance-inducing cellular therapies- An afactt perspective |
Date: | 2019 |
Abstract: | Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the last decade. In this perspective, we will summarize the current perspectives of the clinical application of both tolAPC and Treg, and will address future directions and the importance of immunomonitoring in clinical studies that will result in progress in the field. |
Grants: | European Commission 779316 European Commission 305147 European Commission 260687 Instituto de Salud Carlos III PI14/01175 Instituto de Salud Carlos III PI16/01737 Instituto de Salud Carlos III PI17/01521 |
Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Language: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Subject: | Tolerance ; Dendritic cells ; Regulatory T cells ; Autoimmunity ; Transplantation ; Cell therapy ; Clinic ; Immunomonitoring |
Published in: | Frontiers in immunology, Vol. 10 (Feb. 2019) , art. 181, ISSN 1664-3224 |
20 p, 684.6 KB |